PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
FTXH vs. BBP
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Key characteristics


FTXHBBP
YTD Return10.58%16.54%
1Y Return22.34%44.16%
3Y Return (Ann)3.79%10.13%
5Y Return (Ann)7.84%11.30%
Sharpe Ratio1.872.03
Sortino Ratio2.672.76
Omega Ratio1.331.32
Calmar Ratio1.661.91
Martin Ratio6.916.12
Ulcer Index3.31%7.30%
Daily Std Dev12.30%22.04%
Max Drawdown-32.11%-44.32%
Current Drawdown-1.47%-0.66%

Correlation

-0.50.00.51.00.6

The correlation between FTXH and BBP is 0.61, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Performance

FTXH vs. BBP - Performance Comparison

In the year-to-date period, FTXH achieves a 10.58% return, which is significantly lower than BBP's 16.54% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


0.00%5.00%10.00%15.00%20.00%JuneJulyAugustSeptemberOctoberNovember
8.63%
20.95%
FTXH
BBP

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


FTXH vs. BBP - Expense Ratio Comparison

FTXH has a 0.60% expense ratio, which is lower than BBP's 0.79% expense ratio.


BBP
Virtus LifeSci Biotech Products ETF
Expense ratio chart for BBP: current value at 0.79% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.79%
Expense ratio chart for FTXH: current value at 0.60% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.60%

Risk-Adjusted Performance

FTXH vs. BBP - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for First Trust Nasdaq Pharmaceuticals ETF (FTXH) and Virtus LifeSci Biotech Products ETF (BBP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


FTXH
Sharpe ratio
The chart of Sharpe ratio for FTXH, currently valued at 1.87, compared to the broader market-2.000.002.004.006.001.87
Sortino ratio
The chart of Sortino ratio for FTXH, currently valued at 2.67, compared to the broader market0.005.0010.002.67
Omega ratio
The chart of Omega ratio for FTXH, currently valued at 1.33, compared to the broader market1.001.502.002.503.001.33
Calmar ratio
The chart of Calmar ratio for FTXH, currently valued at 1.66, compared to the broader market0.005.0010.0015.001.66
Martin ratio
The chart of Martin ratio for FTXH, currently valued at 6.91, compared to the broader market0.0020.0040.0060.0080.00100.006.91
BBP
Sharpe ratio
The chart of Sharpe ratio for BBP, currently valued at 2.03, compared to the broader market-2.000.002.004.006.002.03
Sortino ratio
The chart of Sortino ratio for BBP, currently valued at 2.76, compared to the broader market0.005.0010.002.76
Omega ratio
The chart of Omega ratio for BBP, currently valued at 1.32, compared to the broader market1.001.502.002.503.001.32
Calmar ratio
The chart of Calmar ratio for BBP, currently valued at 1.91, compared to the broader market0.005.0010.0015.001.91
Martin ratio
The chart of Martin ratio for BBP, currently valued at 6.12, compared to the broader market0.0020.0040.0060.0080.00100.006.12

FTXH vs. BBP - Sharpe Ratio Comparison

The current FTXH Sharpe Ratio is 1.87, which is comparable to the BBP Sharpe Ratio of 2.03. The chart below compares the historical Sharpe Ratios of FTXH and BBP, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.000.501.001.502.00JuneJulyAugustSeptemberOctoberNovember
1.87
2.03
FTXH
BBP

Dividends

FTXH vs. BBP - Dividend Comparison

FTXH's dividend yield for the trailing twelve months is around 1.52%, while BBP has not paid dividends to shareholders.


TTM202320222021202020192018201720162015
FTXH
First Trust Nasdaq Pharmaceuticals ETF
1.52%1.56%1.10%1.03%0.82%0.67%0.92%2.18%0.19%0.00%
BBP
Virtus LifeSci Biotech Products ETF
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.18%0.00%1.29%

Drawdowns

FTXH vs. BBP - Drawdown Comparison

The maximum FTXH drawdown since its inception was -32.11%, smaller than the maximum BBP drawdown of -44.32%. Use the drawdown chart below to compare losses from any high point for FTXH and BBP. For additional features, visit the drawdowns tool.


-12.00%-10.00%-8.00%-6.00%-4.00%-2.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-1.47%
-0.66%
FTXH
BBP

Volatility

FTXH vs. BBP - Volatility Comparison

The current volatility for First Trust Nasdaq Pharmaceuticals ETF (FTXH) is 3.14%, while Virtus LifeSci Biotech Products ETF (BBP) has a volatility of 4.88%. This indicates that FTXH experiences smaller price fluctuations and is considered to be less risky than BBP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%3.00%4.00%5.00%6.00%7.00%8.00%JuneJulyAugustSeptemberOctoberNovember
3.14%
4.88%
FTXH
BBP